Get the Stockscreener App
8.12
2.92%
0.23
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc Stock (BHC) Latest News
Bausch Health Companies Inc. (NYSE:BHC) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Bausch (BHC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
What is Zacks Research's Estimate for BHC FY2024 Earnings? - MarketBeat
Zacks Research Has Positive View of TSE:BHC FY2024 Earnings - MarketBeat
Traveler's Diarrhea Market Business Strategies, Regional - openPR
Bausch Health Companies (TSE:BHC) Trading Down 0.3%What's Next? - MarketBeat
Scar Treatment Market Detailed In New Research Report 2024 | - openPR
Aesthetic Devices Market in Mexico to Grow by USD 533.06 Million (2024-2028) as AI Impacts Market Trends, Rising Awareness Boosts RevenueTechnavio - Lelezard
LMR Partners LLP Purchases Shares of 400,000 Bausch Health Companies Inc. (NYSE:BHC) - MarketBeat
US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug - Marketscreener.com
Herpes Zoster Oticus Market: Company Profiles, Segment Sizes, - openPR
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis - AccessWire
Bausch Health's Triple-Action Acne Treatment CABTREO Gains Key Canadian Approvals | BHC Stock News - StockTitan
Common Warts Treatment Market Trade Analysis and Statistical - openPR
Underactive Bladder Treatment Market Expected to Reach Huge - openPR
Genital Herpes Treatment Market Global Share, Trends, Business - openPR
Varicella Zoster (HHV-3) Infections Treatment Market Share, - openPR
Vitrectomy Devices Market is expected to reach US$ 2121.3 - openPR
22q11.2 Deletion Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Nobias Therapeutics, Zynerba Pharma, Bausch Health Americas - The Globe and Mail
Actinic Keratosis Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyze | Bausch Health Companies, Sandoz Pharma, Athenex, Almirall, Vidac Pharma, G&E Herbal Biotech - Barchart
Periodontal Therapeutics Market to Grow at a Promising CAGR - openPR
Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC) - Barchart
Myopia and Presbyopia Treatment Market to Grow by USD 9.76 Billion from 2024-2028, as Rising Prevalence Drives Demand with AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN
Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0% CAGR | MarketsandMarkets™ - The Manila Times
Eye Health Supplements Market Trends and Growth Projections - openPR
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
189,000 Shares in Bausch Health Companies Inc. (NYSE:BHC) Bought by Intact Investment Management Inc. - MarketBeat
Bausch Health Companies' SWOT analysis: debt woes cloud strong Q3 stock performance - Investing.com
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales - MSN
Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Bausch Health secures $400 million loan amendment - Investing.com
Bausch Health secures $400 million loan amendment By Investing.com - Investing.com UK
Bausch Health Companies (NYSE:BHC) Price Target Raised to $11.00 at Royal Bank of Canada - MarketBeat
Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript - Insider Monkey
Bausch Health Companies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Bausch Health stock outlook lifted as RBC cites robust Q3 growth and tax benefits - Investing.com
Traders Purchase High Volume of Bausch Health Companies Put Options (NYSE:BHC) - MarketBeat
Toronto Stocks Drop, Canada's GDP Flat in August; Bausch Health Rises on 3Q Beat - Marketscreener.com
Bausch Health Shares Rise on FY Outlook Upgrade, 3Q Beat - MarketWatch
Bausch Health Companies (NYSE:BHC) Trading 8.7% Higher on Better-Than-Expected Earnings - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 8.4% Following Earnings Beat - MarketBeat
BHCBausch Health Companies Inc. Latest Stock News & Market Updates - StockTitan
Bausch: Q3 Earnings Snapshot - Houston Chronicle
Bausch Health Reports Growth Amid Improved Financials - TipRanks
Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance
Bausch Health Companies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bausch Health Announces Third Quarter 2024 Results - AccessWire
Gastroparesis Treatment Market Top Trends and Growth Analysis: - openPR
Bausch Health Companies Q3 2024 Earnings Preview - MSN
Onychomycosis Treatment Market Size, Industry Analysis, - openPR
Actinic Keratosis Treatment Market Expected to Reach Huge - openPR
Canada Aesthetic Devices Market Size, Share, Industry Growth, - openPR
Bausch Health Companies Inc. and Salix Pharmaceuticals Announce Results of an Analysis of Xifaxan Monotherapy Will Be Presented During A Presidential Plenary Session of the American College of Gastroenterology 2024 Annual Scientific Meeting Taking - Marketscreener.com
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence - StockTitan
TD COWEN Downgrades Bausch Health Companies (BHC) - MSN
Deal Dispatch: TKO Buys Bull Riding, Radford Motors Is BankruptApollo Global Management (NYSE:APO), Bausch Health Companies (NYSE:BHC) - Benzinga
Bausch Health Companies (NYSE:BHC) Lifted to "Buy" at StockNews.com - MarketBeat
0.83%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):